Botulinum toxin for post-stroke spastic hypertonia: a review of its efficacy and application in clinical practice
Annals of the Academy of Medicine, Singapore
;
: 22-30, 2007.
Artículo
en Inglés
| WPRIM
| ID: wpr-275237
ABSTRACT
Botulinum toxins (BTX) have revolutionised the management of focal post-stroke spastic hypertonia. Published literature has supported the efficacy and safety of BTX in reducing spastic hypertonia but has not convincingly demonstrated the ability to enhance function. While clinicians and stroke survivors have reported impressive clinical outcomes, randomised, controlled trials (RCTs), have demonstrated only significant improvement in muscle tone but not functional changes. This paper will review the evidence supporting the efficacy of BTX for spastic hypertonia and discuss current clinical practice.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Resultado del Tratamiento
/
Toxinas Botulínicas Tipo A
/
Recuperación de la Función
/
Accidente Cerebrovascular
/
Usos Terapéuticos
/
Quimioterapia
/
Hipertonía Muscular
/
Fármacos Neuromusculares
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Humanos
Idioma:
Inglés
Revista:
Annals of the Academy of Medicine, Singapore
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS